Swarnaprasu Biotech Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 5.00 M
- Company Age 9 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.90 M
About Swarnaprasu Biotech
Swarnaprasu Biotech Private Limited (SBPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 09 October 2015 (Nine years and four months 7 days old ). Its registered office is in Khorda, Odisha, India.
The Company is engaged in the Research & Development Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹3.90 M.
Mahadev Jena, Ashok Patra, Sanjukta Patra, and Two other members serve as directors at the Company.
Company Details
-
Location
Khorda, Odisha, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24230OR2015PTC019474
-
Company No.
019474
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
09 Oct 2015
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Cuttack
Industry
Who are the key members and board of directors at Swarnaprasu Biotech?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjukta Patra
|
Managing Director | 09-Oct-2015 | Current |
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Ashok Patra
|
Director | 09-Oct-2015 | Current |
|
Mahadev Jena
|
Director | 22-Feb-2020 | Current |
|
Nibedita Bhatta
|
Director | 11-Oct-2018 | Current |
|
Sashmita Bardhan
|
Director | 11-Oct-2018 | Current |
Financial Performance of Swarnaprasu Biotech.
Swarnaprasu Biotech Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Swarnaprasu Biotech?
In 2017, Swarnaprasu Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹3.90 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.39 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 May 2020 | Others | ₹2.50 M | Open |
| 02 Dec 2019 | Others | ₹1.40 M | Open |
How Many Employees Work at Swarnaprasu Biotech?
Unlock and access historical data on people associated with Swarnaprasu Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Swarnaprasu Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Swarnaprasu Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.